Biomea Fusion (BMEA) Stock Forecast & Price Target

$1.50 +0.03 (+1.69%)

As of 03:50 PM Eastern

Compare

Biomea Fusion - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 10 Analyst Ratings

Sell
1

Hold
0

Buy
9

Based on 10 Wall Street analysts who have issued ratings for Biomea Fusion in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 1 has given a sell rating, 8 have given a buy rating, and 1 has given a strong buy rating for BMEA.

Consensus Price Target

$9.50
531.23% Upside

According to the 10 analysts' twelve-month price targets for Biomea Fusion, the average price target is $9.50. The highest price target for BMEA is $18.00, while the lowest price target for BMEA is $5.00. The average price target represents a forecasted upside of 531.23% from the current price of $1.51.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for BMEA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Biomea Fusion and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BMEA Analyst Ratings Over Time

Type	Current Forecast 5/5/25 to 5/5/26	1 Month Ago 4/5/25 to 4/5/26	3 Months Ago 2/4/25 to 2/4/26	1 Year Ago 5/5/24 to 5/5/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	9 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$9.50	$9.57	$8.78	$24.80
Forecasted Upside	531.23% Upside	521.52% Upside	705.30% Upside	1,140.00% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

BMEA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BMEA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Biomea Fusion Stock vs. The Competition

Type	Biomea Fusion	Medical Companies	S&P 500
Consensus Rating Score	2.90	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	535.03% Upside	912.71% Upside	15.29% Upside
News Sentiment Rating	Positive News See Recent BMEA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/5/2026	Citizens Jmp 4 of 5 stars	Jonathan Wolleben 4 of 5 stars	Initiated Coverage	Market Outperform	$9.00	+508.10%
4/28/2026	D. Boral Capital 3 of 5 stars	Jason Kolbert 3 of 5 stars	Reiterated Rating	Buy	$12.00	+625.07%
4/20/2026	Weiss Ratings Not Rated		Reiterated Rating	Sell (E+)
3/27/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$6.00 ➝ $7.00	+428.30%
1/13/2026	Rodman & Renshaw Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy	$8.00	+446.07%
8/28/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roger Song Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$5.00	+168.82%
8/6/2025	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Farmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Outperform	$30.00 ➝ $10.00	+555.73%
8/5/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
6/3/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Tenthoff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight	$7.00	+351.61%
5/6/2025	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$40.00 ➝ $18.00	+800.00%

4/2/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Lawson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$11.00 ➝ $3.00	+46.70%
9/27/2024	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srikripa Devarakonda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$54.00 ➝ $54.00	+464.26%
8/29/2024	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quibria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight	$25.00	+231.56%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:45 PM ET.

BMEA Forecast - Frequently Asked Questions

: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Biomea Fusion is $9.50, with a high forecast of $18.00 and a low forecast of $5.00.
: 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Biomea Fusion in the last twelve months. There is currently 1 sell rating, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BMEA shares.
: According to analysts, Biomea Fusion's stock has a predicted upside of 531.23% based on their 12-month stock forecasts.
: Biomea Fusion has been rated by research analysts at Citigroup, Citizens Jmp, D. Boral Capital, and Weiss Ratings in the past 90 days.
: Analysts like Biomea Fusion more than other "medical" companies. The consensus rating for Biomea Fusion is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how BMEA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Biomea Fusion Recommendations

This page (NASDAQ:BMEA) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biomea Fusion (BMEA) Stock Forecast & Price Target

Biomea Fusion - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BMEA Analyst Ratings Over Time

BMEA Analyst Recommendations By Month

BMEA Price Targets by Month

Biomea Fusion Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

BMEA Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Biomea Fusion Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biomea Fusion (BMEA) Stock Forecast & Price Target

Biomea Fusion - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BMEA Analyst Ratings Over Time

BMEA Analyst Recommendations By Month

BMEA Price Targets by Month

Biomea Fusion Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

BMEA Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Biomea Fusion Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools